New Class of Inhibitors of Amyloid-beta Fibril Formation. IMPLICATIONS FOR THE MECHANISM OF PATHOGENESIS IN ALZHEIMER'S DISEASE (Q22248067)

David

Balakhaneh

3

1 reference

7 February 2023

Aneel Aggarwal

Aneel

Aggarwal

4

1 reference

7 February 2023

Saul Teichberg

Saul

Teichberg

5

1 reference

7 February 2023

David J E Callaway

David J E

Callaway

Journal of Biological Chemistry

6

1 reference

7 February 2023

language of work or name

English

0 references

publication date

6 August 2002

0 references

published in

0 references

volume

277

0 references

issue

45

0 references

page(s)

42881-42890

0 references

cites work

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

New developments in animal models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Secretase as a target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

The challenge of inhibiting Abeta polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Amyloid diseases: abnormal protein aggregation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Alzheimer's disease: an overview of current and emerging therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Inhibiting transthyretin amyloid fibril formation via protein stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Peptide inhibitors of beta amyloid aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Molecular structures from low angle X-ray and neutron scattering studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

An improved function for fitting sedimentation velocity data for low-molecular-weight solutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Boundary analysis in sedimentation velocity experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Catecholamines potentiate amyloid beta-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Interactions of apomorphine with serum and tissue proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Apomorphine for motor fluctuations and freezing in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Mutations in the transmembrane domain of APP altering gamma-secretase specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

[The autoxydation of apomorphin]

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Stability of apomorphine in plasma and its determination by high-performance liquid chromatography with electrochemical detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Auto-oxidation of apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Stability of apomorphine in solutions containing ascorbic acid and bisulfite and effects of antioxidants on apomorphine-induced cage climbing and hypothermia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Amyloid beta peptides do not form peptide-derived free radicals spontaneously, but can enhance metal-catalyzed oxidation of hydroxylamines to nitroxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Antioxidant action of benzylisoquinoline alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

inferred from DOI database lookup

7 January 2021

based on heuristic

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200

inferred from DOI database lookup

7 January 2021

based on heuristic

A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206593200